Role of miR-148a in Mitigating Hepatic Ischemia-Reperfusion Injury by Repressing the TLR4 Signaling Pathway via Targeting CaMKII α in Vivo and in Vitro

Conclusion: Taken together, we conclude that miR-148a may mitigate hepatic I/R injury by ameliorating TLR4-mediated inflammationvia targeting CaMKII αin vitro andin vivo.Cell Physiol Biochem 2018;49:2060 –2072

https://www.karger.com/Article/FullText/493716

Source: Cellular Physiology and Biochemistry - September 21, 2018 Category: Cytology Source Type: research

Role of miR-148a in Mitigating Hepatic Ischemia-Reperfusion Injury by Repressing the TLR4 Signaling Pathway via Targeting CaMKII α < b > < i > in Vivo < /i > < /b > and < b > < i > in Vitro < /i > < /b >